FEATURED ARTICLES

• Dr. Bobby Gaspar On Manufacturing, Commercialization Challenges

  Orchard Therapeutics CEO Dr. Bobby Gaspar, M.D., Ph.D. is one of only a handful of gene therapy leaders to see the light of market-approved therapy. Here, he offers advice for those seeing manufacturing, regulatory, and reimbursement challenges for the first time.

• Beating Stem Cell Sourcing, Exosome Production Challenges
• Is Your Definition Of Quality Culture The Same As The FDA's?
• New Podcast: Building Blocks Of The Biopharma Business
• Introducing The Business Of Biotech Podcast